A team working out of UC Irvine’s Center for the Study of Cannabis has completed a study indicating marijuana can be an effective treatment for pain accompanying sickle cell anemia. The findings by UCI’s Kalpna Gupta and UC San Francisco’s Donald Abrams appear in JAMA Network Open.
- Gupta and Abrams’ trial is the first of its kind to employ gold-standard methods—double-blind, placebo-controlled, randomized—to assess cannabis’s potential for alleviating pain associated with sickle cell disease.
- The results go past confirmation that vaporized weed diminishes chronic pain among sufferers. “They also suggest that sickle cell patients may be able to mitigate their pain with cannabis — and that cannabis might help society address the public health crisis related to opioids,” says Kalpna Gupta, a professor of medicine on the faculty of UCI’s Center for the Study of Cannabis. “Of course, we still need larger studies with more participants to give us a better picture of how cannabis could benefit people with chronic pain.”
- In a pandemic, your bud tender can no longer be your first line of marketing. That is just one of the unassailable facts of marketing and advertising in our strange New Normal.
Cannabis Industry Journal